• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of MicroRNA-sensitive Oncolytic Sindbis virus for Oral-cancer therapy

Research Project

Project/Area Number 24792175
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Surgical dentistry
Research InstitutionChiba University

Principal Investigator

SAITO KENGO  千葉大学, 医学(系)研究科(研究院), 講師 (70451755)

Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords腫瘍溶解性ウイルス / microRNA / 口腔癌 / シンドビスウイルス / マイクロRNA / 癌
Outline of Final Research Achievements

The cellular tropisms of eukaryotic viruses are shaped by their need for entry receptors and intracellular transcription factors. Here we show that viral tropisms can also be regulated by tissue-specific microRNAs (miRNA). Since miRNA125b and miR100 are downregulated in oral cancer but highly expressed in normal tissue, we engineered a microRNA-sensitive virus containing target sites for those microRNAs in the 3′-untranslated region of an oncolytic Sindbis virus. The recombinant virus still propagated in cancer cells but could not replicate in cells expressing complementary miRNAs, suggesting a new modality of replicating viruses for cancer therapy.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (5 results)

All 2014 2013 2012

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Open Access: 2 results) Presentation (2 results)

  • [Journal Article] Suppression of La Antigen Exerts Potential Antiviral Effects against Hepatitis A Virus.2014

    • Author(s)
      Jiang X, Kanda T, Wu S, Nakamoto S, Saito K, Shirasawa H, Kiyohara T, Ishii K, Wakita T, Okamoto H, Yokosuka O.
    • Journal Title

      PLoS One.

      Volume: 9 Issue: 7 Pages: e101993-e101993

    • DOI

      10.1371/journal.pone.0101993

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment.2014

    • Author(s)
      Nakamoto S, Kanda T, Nakaseko C, Sakaida E, Ohwada C, Takeuchi M, Takeda Y, Mimura N, Iseki T, Wu S, Arai M, Imazeki F, Saito K, Shirasawa H, Yokosuka O.
    • Journal Title

      Int J Mol Sci

      Volume: 15 Issue: 11 Pages: 21455-67

    • DOI

      10.3390/ijms151121455

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Lipocalin-2 is associated with radioresistance in oral cancer and lung cancer cells.2013

    • Author(s)
      椎葉正史、齋藤謙悟、鵜澤一弘
    • Journal Title

      International journal of oncology

      Volume: 42 Issue: 4 Pages: 1197-1204

    • DOI

      10.3892/ijo.2013.1815

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Presentation] The effects of cancer-targeted liposomes loaded with PDE inhibitors on the cisplatin-resistance on cancer cells2013

    • Author(s)
      齋藤 謙悟
    • Organizer
      第72回 日本癌学会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Related Report
      2013 Research-status Report
  • [Presentation] シスプラチン耐性阻害剤含有腫瘍標的リポソームの効果2012

    • Author(s)
      齋藤 謙悟
    • Organizer
      第71回 日本癌学会
    • Place of Presentation
      ロイトン札幌(札幌)
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi